118 related articles for article (PubMed ID: 30735306)
1. A Cell Culture Platform for the Cultivation of Cryptosporidium parvum.
Jossé L; Bones AJ; Purton T; Michaelis M; Tsaousis AD
Curr Protoc Microbiol; 2019 Jun; 53(1):e80. PubMed ID: 30735306
[TBL] [Abstract][Full Text] [Related]
2. A cell culture platform for Cryptosporidium that enables long-term cultivation and new tools for the systematic investigation of its biology.
Miller CN; Jossé L; Brown I; Blakeman B; Povey J; Yiangou L; Price M; Cinatl J; Xue WF; Michaelis M; Tsaousis AD
Int J Parasitol; 2018 Mar; 48(3-4):197-201. PubMed ID: 29195082
[TBL] [Abstract][Full Text] [Related]
3. The Oesophageal Squamous Cell Carcinoma Cell Line COLO-680N Fails to Support Sustained
Vélez J; Silva LMR; Kamena F; Daugschies A; Mazurek S; Taubert A; Hermosilla C
Pathogens; 2021 Dec; 11(1):. PubMed ID: 35055997
[No Abstract] [Full Text] [Related]
4. A novel, stain-free, natural auto-fluorescent signal, Sig M, identified from cytometric and transcriptomic analysis of infectivity of
Ogbuigwe P; Roberts JM; Knox MA; Heiser A; Pita A; Haack NA; Garcia-Ramirez JC; Velathanthiri N; Biggs PJ; French NP; Hayman DTS
Front Cell Infect Microbiol; 2023; 13():1178576. PubMed ID: 37284498
[TBL] [Abstract][Full Text] [Related]
5. Blind trials evaluating in vitro infectivity of Cryptosporidium oocysts using cell culture immunofluorescence.
Bukhari Z; Holt DM; Ware MW; Schaefer FW
Can J Microbiol; 2007 May; 53(5):656-63. PubMed ID: 17668024
[TBL] [Abstract][Full Text] [Related]
6. Continuous culture of Cryptosporidium parvum using hollow fiber technology.
Morada M; Lee S; Gunther-Cummins L; Weiss LM; Widmer G; Tzipori S; Yarlett N
Int J Parasitol; 2016 Jan; 46(1):21-9. PubMed ID: 26341006
[TBL] [Abstract][Full Text] [Related]
7. Assessment of differences between DNA content of cell-cultured and freely suspended oocysts of Cryptosporidium parvum and their suitability as DNA standards in qPCR.
Woolsey ID; Blomstrand B; Øines Ø; Enemark HL
Parasit Vectors; 2019 Dec; 12(1):596. PubMed ID: 31856894
[TBL] [Abstract][Full Text] [Related]
8. Generating and Maintaining Transgenic Cryptosporidium parvum Parasites.
Pawlowic MC; Vinayak S; Sateriale A; Brooks CF; Striepen B
Curr Protoc Microbiol; 2017 Aug; 46():20B.2.1-20B.2.32. PubMed ID: 28800157
[TBL] [Abstract][Full Text] [Related]
9. A chicken embryo model for the maintenance and amplification of Cryptosporidium parvum and Cryptosporidium baileyi oocysts.
Holubová N; Sak B; Schulzová T; Konečný R; Rost M; Tůmová L; McEvoy J; Kváč M
Eur J Protistol; 2020 Aug; 75():125718. PubMed ID: 32604041
[TBL] [Abstract][Full Text] [Related]
10. Combination of cell culture and quantitative PCR (cc-qPCR) to assess disinfectants efficacy on Cryptosporidium oocysts under standardized conditions.
Shahiduzzaman M; Dyachenko V; Keidel J; Schmäschke R; Daugschies A
Vet Parasitol; 2010 Jan; 167(1):43-9. PubMed ID: 19850414
[TBL] [Abstract][Full Text] [Related]
11. Real-time nucleic acid sequence-based amplification (NASBA) assay targeting MIC1 for detection of Cryptosporidium parvum and Cryptosporidium hominis oocysts.
Hønsvall BK; Robertson LJ
Exp Parasitol; 2017 Jan; 172():61-67. PubMed ID: 27998735
[TBL] [Abstract][Full Text] [Related]
12. Complete development of Cryptosporidium parvum in rabbit chondrocytes (VELI cells).
Lacharme L; Villar V; Rojo-Vazquez FA; Suárez S
Microbes Infect; 2004 May; 6(6):566-71. PubMed ID: 15158190
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Culture of Cryptosporidium parvum Using Hollow Fiber Bioreactor: Applications for Simultaneous Pharmacokinetic and Pharmacodynamic Evaluation of Test Compounds.
Yarlett N; Morada M; Gobin M; Van Voorhis W; Arnold S
Methods Mol Biol; 2020; 2052():335-350. PubMed ID: 31452171
[TBL] [Abstract][Full Text] [Related]
14. Complete development of Cryptosporidium parvum in host cell-free culture.
Hijjawi NS; Meloni BP; Ng'anzo M; Ryan UM; Olson ME; Cox PT; Monis PT; Thompson RC
Int J Parasitol; 2004 Jun; 34(7):769-77. PubMed ID: 15157759
[TBL] [Abstract][Full Text] [Related]
15. Morphology and in vitro infectivity of sporozoites of Cryptosporidium parvum.
Petry F; Kneib I; Harris JR
J Parasitol; 2009 Oct; 95(5):1243-6. PubMed ID: 19492897
[TBL] [Abstract][Full Text] [Related]
16. Genomic and virulence analysis of in vitro cultured Cryptosporidium parvum.
Yarlett N; Morada M; Schaefer DA; Ackman K; Carranza E; Baptista RP; Riggs MW; Kissinger JC
PLoS Pathog; 2024 Feb; 20(2):e1011992. PubMed ID: 38416794
[TBL] [Abstract][Full Text] [Related]
17. Cryopreservation of infectious Cryptosporidium parvum oocysts achieved through vitrification using high aspect ratio specimen containers.
Jaskiewicz JJ; Sevenler D; Swei AA; Widmer G; Toner M; Tzipori S; Sandlin RD
Sci Rep; 2020 Jul; 10(1):11711. PubMed ID: 32678171
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Culture of Cryptosporidium parvum Using Stem Cell-Derived Intestinal Epithelial Monolayers.
Wilke G; Wang Y; Ravindran S; Stappenbeck T; Witola WH; Sibley LD
Methods Mol Biol; 2020; 2052():351-372. PubMed ID: 31452172
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Cryptosporidium oocyst recovery methods for their applicability for monitoring of consumer-ready fresh shellfish.
Kaupke A; Osiński Z; Rzeżutka A
Int J Food Microbiol; 2019 May; 296():14-20. PubMed ID: 30826538
[TBL] [Abstract][Full Text] [Related]
20. Genotyping of Cryptosporidium parvum with microsatellite markers.
Widmer G; Feng X; Tanriverdi S
Methods Mol Biol; 2004; 268():177-87. PubMed ID: 15156029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]